Stephen Hull, based in Washington, DC, US, is currently a Regional Medical Director (RMD, Sr. MSL), Clinical Medical Affairs at CardioDx, bringing experience from previous roles at Novartis, Phaidon Global Company (PGC), Genentech and Mylan. Stephen Hull holds a 2020 - 2022 Master of Business Administration - MBA in 3.93 @ American Public University. With a robust skill set that includes Leadership, Presentation Skills, Clinical Trials, Medical Writing, Ich Gcp and more, Stephen Hull contributes valuable insights to the industry. Stephen Hull has 2 emails on RocketReach.